Innovation and Enterprise Value-research of the pharmaceutical industry-

Research Project

Project/Area Number	22530393
Research Category	Grant-in-Aid for Scientific Research (C)
Allocation Type	Single-year Grants
Section	一般
Research Field	Business administration
Research Institution	Saitama University
Principal Investigator	KANEKO Shigeru 埼玉大学, 経済学部, 教授 (20204555)
Project Period (FY)	2010 – 2012
Project Status	Completed (Fiscal Year 2012)
Budget Amount *help	¥3,250,000 (Direct Cost: ¥2,500,000、Indirect Cost: ¥750,000) Fiscal Year 2012: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000) Fiscal Year 2011: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000) Fiscal Year 2010: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Keywords	企業価値 / 経営分析 / 売上高営業利益率 / ガバナンスコスト / のれん / 統治費用 / バイオテクノロジー / 技術移転機関 / バイオテクノロジー企業 / 薬効探索 / 資金調達
Research Abstract	Since 2000,Japanese pharmaceutical M&A have occurred.In this research, I used business analysis approach. The profitability of Japanese Big Pharma steadily declined because the governance cost and the good・will impact the profitability adversely.